Upside – $MEDS +36% (preliminary September pharmacy revenue exceeded $1M, rising more than 66% from July) – $ACN +17% (Q4 beat with $22.2B of bookings and stronger operating margins) – $ABAT +13% (receives federal approval to export up to $100M of recycled black-mass material) – $QSI +13% (no clear fresh catalyst identified; unusually large move …
Read in context ›Synopsys Stock (SNPS)
Track Synopsys stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
SNPS
Synopsys
technology
At close
$509.99
▲ +12.24 (+2.46%)
Oct 9, 4:00 PM ET
After-hours
$509.00
▼ -0.99 (-0.19%)
Oct 9, 7:57 PM ET
Market Cap
$95.39B
P/E Ratio
88.1x
1Y Return
+5.28%
EPS (TTM)
$5.66
Read the latest TheStreet Pro articles mentioning Synopsys, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
15 articlesDaily Diary Mentions
2 mentionsUpside, Downside Movers in the Morning U.S. Select Premarket Movers Upside: ( MOBX ) +55% (earnings, guidance) AIRI +42% (awarded $110 million, seven-year contract for the production of Thrust Struts used in the Geared Turbo-Fan [GTF] aircraft jet engine) PTON +13% (earnings, guidance) Z…
Read in context ›